New data from Galderma's aesthetics portfolio to be presented at 2022 ASDS Annual Meeting
New pivotal study data demonstrating the safety and effectiveness of Sculptra, the only U.S. FDA-approved PLLA biostimulator, in the correction of cheek...
Stay updated with breaking news from Us Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New pivotal study data demonstrating the safety and effectiveness of Sculptra, the only U.S. FDA-approved PLLA biostimulator, in the correction of cheek...
/PRNewswire/ -- DHL, one of the world's leading providers of international express shipping services, is proud to announce a new partnership with BigCommerce...
EQS-News: MorphoSys AG / Key word(s): MiscellaneousMorphoSys Presents New Long-Term Data from L-MIND Suggesting Durable Response to Treatment with Monjuvi® (tafasitamab-cxix) for Patients with R/R DLBCL 28.09.2022 / 22:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Media Release BOS...
BOSTON - MorphoSys USA, Inc., a fully owned subsidiary of MorphoSys AG , announced data from the ongoing L-MIND study showing that Monjuvi plus lenalidomide followed by Monjuvi monotherapy provided... | September 29, 2022
Jonah Keel and Briana Richard Elevated to Senior Vice President and Vice President, RespectivelyDivision's Gaming Team Adds Industry Veteran Blake Shuster, Former Head of US Communications for Red Bull